IRIS
MARAFINI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.749
AS - Asia 2.946
EU - Europa 1.852
SA - Sud America 378
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 18.975
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.653
SG - Singapore 1.551
CN - Cina 510
IT - Italia 465
BR - Brasile 314
HK - Hong Kong 283
RU - Federazione Russa 280
DE - Germania 198
FI - Finlandia 188
IE - Irlanda 179
VN - Vietnam 160
BD - Bangladesh 142
UA - Ucraina 120
GB - Regno Unito 108
FR - Francia 96
JP - Giappone 73
CA - Canada 50
KR - Corea 48
SE - Svezia 45
PL - Polonia 43
IN - India 39
NL - Olanda 33
MX - Messico 24
ID - Indonesia 22
AT - Austria 20
ES - Italia 20
IQ - Iraq 20
AR - Argentina 19
TR - Turchia 19
EC - Ecuador 13
BE - Belgio 12
ZA - Sudafrica 12
CL - Cile 11
LT - Lituania 11
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CO - Colombia 7
MA - Marocco 7
MY - Malesia 7
PK - Pakistan 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
GR - Grecia 5
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
JO - Giordania 5
PH - Filippine 5
TN - Tunisia 5
A1 - Anonimo 4
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
NP - Nepal 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
RO - Romania 3
VE - Venezuela 3
AM - Armenia 2
BO - Bolivia 2
BS - Bahamas 2
CR - Costa Rica 2
HN - Honduras 2
KE - Kenya 2
LK - Sri Lanka 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
Totale 18.974
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.135
Wilmington 2.922
Houston 2.766
Singapore 722
Fairfield 524
Ashburn 467
San Jose 308
Ann Arbor 295
Hong Kong 281
Chandler 268
Seattle 231
Council Bluffs 220
Beijing 183
Cambridge 180
Rome 167
Dublin 152
Helsinki 146
Medford 123
Santa Clara 123
Los Angeles 105
New York 98
Jacksonville 96
The Dalles 94
Dearborn 83
Tokyo 67
Monte Vista 60
Lawrence 56
Chicago 52
Lauterbourg 52
Buffalo 50
Ho Chi Minh City 49
Milan 47
Dallas 41
Moscow 38
North Charleston 36
Hanoi 35
San Diego 35
Zhengzhou 32
Nuremberg 26
São Paulo 24
Menlo Park 23
North Bergen 23
Atlanta 22
Indianapolis 21
Kraków 21
London 20
Toronto 19
Warsaw 19
Rio de Janeiro 18
Colorado Springs 17
Munich 17
Redondo Beach 17
Shanghai 17
Chennai 16
Brooklyn 14
Denver 14
Seoul 14
Frankfurt am Main 13
Jakarta 13
Orem 13
Baghdad 12
Brussels 12
Montreal 12
Naples 12
San Francisco 12
Lappeenranta 11
Phoenix 11
Bologna 10
Columbus 10
Groningen 10
Norwalk 10
Redwood City 10
Stockholm 9
Vienna 9
Curitiba 8
Da Nang 8
Johannesburg 8
Kunming 8
Miami 8
Tashkent 8
Amsterdam 7
Belo Horizonte 7
Boardman 7
Del Norte 7
Hải Dương 7
Madrid 7
Mexico City 7
Mountain View 7
Ankara 6
Boston 6
Brescia 6
Chittagong 6
City of London 6
Kuala Lumpur 6
Salt Lake City 6
Verona 6
Bari 5
Charlotte 5
Chengdu 5
Dhaka 5
Totale 15.062
Salva come PNG Salva come JPEG
Nome #
Pyoderma gangrenosum in refractory celiac disease: a case report 618
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 522
Interleukin-34 sustains inflammatory pathways in the gut 515
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 510
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 491
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 479
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 477
The dual role of Smad7 in the control of cancer growth and metastasis 477
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 476
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 464
An overview of the role of innate lymphoid cells in gut infections and inflammation 461
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 459
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 455
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 453
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 453
Antisense approach to inflammatory bowel disease: Prospects and challenges 452
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 452
TGF-Beta signaling manipulation as potential therapy for IBD 451
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 451
null 442
Defective expression of scavenger receptors in celiac disease mucosa 437
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 429
The TGF-β/Smad System in IBD Pathogenesis 418
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man 413
Targeting integrins and adhesion molecules to combat inflammatory bowel disease 390
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 385
Smad7 positively regulates keratinocyte proliferation in psoriasis 384
Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad 378
Proteinase activated-receptors-associated signaling in the control of gastric cancer 365
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 335
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 265
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 255
Precision Medicine in Inflammatory Bowel Diseases 248
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 232
Inflammatory cytokines: from discoveries to therapies in IBD 224
Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients 219
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 211
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 196
Association between celiac disease and cancer 152
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 145
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 140
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 139
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 135
Novel therapeutic options for people with ulcerative colitis: an update on recent developments with Janus Kinase (JAK) inhibitors 129
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 117
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders 110
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 104
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 104
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 97
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 94
Low frequency of COVID-19 in inflammatory bowel diseases 92
Preventable predictive factors of post-colonoscopy colorectal cancer in inflammatory bowel disease 89
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 83
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 81
Metalloproteinases in inflammatory bowel diseases 81
Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa 79
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease 78
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features 77
Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 75
Interleukin-34 promotes tumorigenic signals for colon cancer cells 75
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 69
Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease 66
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab 65
Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy 63
Long-term outcomes and predictive factors of hospitalized patients with severe ulcerative colitis treated with intravenous corticosteroids 63
Frequency of dysplasia in endoscopically resected pseudopolyps in inflammatory bowel diseases 62
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease 60
Best of UEG Week 2024 59
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 59
No effect of a liquid diet in the management of patients with stricturing Crohn’s disease 59
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation 58
Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases 58
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term 57
Natural History of Ulcerative Colitis with Coexistent Colonic Diverticulosis. 56
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature 53
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 51
Clinical outcome after entero-enteric anastomosis for Crohn’s disease: a case-control study 50
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old data 50
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters? 49
Vedolizumab and new‐onset spondyloarthritis: Debunking the myth 43
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice 41
High Smad7 marks inflammation in patients with chronic pouchitis 39
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease 37
Quality of clinical guidelines: It matters as it impacts patient care 34
Treatment options for refractory ulcerative colitis: Small molecules, big effects 34
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study 32
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 27
Inflammatory bowel disease: new therapies from antisense oligonucleotides 24
Immune cell dynamics and mechanisms of epithelial injury in celiac disease 23
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease 22
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients 21
Molecular Insights into Helicobacter pylori-Induced Gastritis and Gastric Cancer 20
Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model 19
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection 18
Reduced Taurine Serum Levels in Inflammatory Bowel Disease 18
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary Care 18
Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy 17
TGF-?? activity restoration and phosphodiesterase 4 inhibition as therapeutic options for inflammatory bowel diseases 15
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy 15
CD19 CAR T-Cell Therapy for Refractory Ulcerative Colitis 15
Totale 19.257
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202136 0 0 0 0 0 0 0 0 0 0 0 36
2021/2022610 35 24 23 29 8 45 24 18 139 64 55 146
2022/2023665 65 77 16 85 60 151 62 34 48 21 29 17
2023/2024283 33 5 13 7 20 48 23 53 5 5 17 54
2024/20252.428 34 399 332 131 52 241 132 82 195 215 364 251
2025/20264.321 311 159 386 274 350 191 565 409 445 358 625 248
Totale 19.421